A cost analytic model to determine the least costly inpatient erythropoiesis stimulating therapy (EST) regimen.

243.

  • Mody, Samir Pharm.D., M.B.A.
  • Watson, Sue Pharm.D.
  • Fastenau, John M.P.H.
  • Decter, Adam M.B.A., MA
  • Little, Jennifer B.A.
  • Duh, Mei-Sheng M.P.H., Sc.D.

  • 1Ortho Biotech Clinical Affairs, LLC, Bridgewater, NJ

    2Analysis Group, Inc, Boston, MA.

Encore Presentations: Abstracts marked with an “E” are Encore Presentations. Encore Presentations undergo the same peer review process as do Original Presentations, but may have been presented elsewhere or published in abstract form only prior to the 2004 Annual Meeting. For Encore Presentations, the abstract title, authors, and original citation (if provided) are published in Pharmacotherapy. The full abstract will be published in the meeting program book.

ORIGINAL RESEARCH

These papers describe original research in therapeutics, pharmacokinetics, pharmacodynamics, pharmacoeconomics, pharmacoepidemiology, and pharmacogenomics.

Pharmacotherapy: The Journal Of Human Pharmacology & Drug Therapy 24(10):p 1456, October 2004.
Copyright © 2004 John Wiley & Sons, Inc.